ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

Clinical trial NCT06195709 · RECRUITING

Trial details

NCT number: NCT06195709
Sponsor: Institut Curie
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Carcinoma

Start date: 2024-05-27
Primary completion: 2029-09-27
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.